List of Revvity Research & Development Customers
Waltham, 2451, MA,
United States
Since 2010, our global team of researchers has been studying Revvity Research & Development customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Revvity Research & Development for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Revvity Research & Development for Clinical Trial Management include: Eli Lilly, a United States based Life Sciences organisation with 50605 employees and revenues of $65.18 billion, Merck Group, a Germany based Life Sciences organisation with 59020 employees and revenues of $23.27 billion, Camurus, a Sweden based Life Sciences organisation with 250 employees and revenues of $66.0 million and many others.
Contact us if you need a completed and verified list of companies using Revvity Research & Development, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Revvity Research & Development customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Life Sciences | 50605 | $65.2B | United States | Revvity | Revvity Research & Development | Clinical Trial Management | 2025 | n/a |
|
|
|
|
Life Sciences | 59020 | $23.3B | Germany | Revvity | Revvity Research & Development | Clinical Trial Management | 2024 | n/a |
|
|
|
|
Life Sciences | 250 | $66M | Sweden | Revvity | Revvity Research & Development | Clinical Trial Management | 2023 | n/a |
|
Buyer Intent: Companies Evaluating Revvity Research & Development
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||